Dexcom ONE® and Dexcom ONE+®

Clinical Indication

Diabetes Continuous glucose monitoring (CGM)

Comments

Dexcom ONE^®and Dexcom ONE+ ® are approved for use in Leicester, Leicestershire and Rutland for diabetes glucose monitoring where a patient meets the criteria detailed in the LLR APC position statement.

Dexcom ONE® will be discontinued on 31st March 2026 and therefore all patients using this device should be switched over to the updated Dexcom ONE+. All new patients must be started on Dexcom ONE+

Date of classification

February 2026

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .